Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.
HGER vs IBB: how they differ
HGER and IBB hold 0% of their weight in the same names, and HGER returned more over the year.
Harbor Commodity All-Weather Strategy ETF and iShares Biotechnology ETF.
What they hold in common
By the books each fund has filed, HGER and IBB hold 0% of their money in the same securities at the same weight.
| Only in HGER | Only in IBB |
|---|---|
| United States Treasury 17.98% | Vertex Pharmaceuticals, Inc. 8.09% |
| United States Treasury 17.65% | Amgen, Inc. 7.84% |
| United States Treasury 17.49% | Gilead Sciences, Inc. 6.85% |
| United States Treasury 16.56% | Regeneron Pharmaceuticals, Inc. 4.91% |
| United States Treasury 13.97% | Argenx SE 3.76% |
| United States Treasury 12.50% | Alnylam Pharmaceuticals, Inc. 3.12% |
| United States Treasury 3.85% | Natera, Inc. 2.89% |
| Revolution Medicines, Inc. 2.78% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Apr 30, 2026 and Jun 30, 2026.
| HGER Harbor Commodity All-Weather Strategy ETF | IBB iShares Biotechnology ETF | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | Harbor | iShares |
| What it is | Harbor Commodity All-Weather Strategy | Biotechnology |
| Total return, 1 year | +52.8% | +41.5% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | +35.3 pts | +24.0 pts |
| Expense ratio | 0.68% | 0.44% |
| Already in the S&P 500 | 0.0% | 35.6% |
| Holdings | 7 | 248 |
HGER in plain words
HGER is an index equity fund tracking the Harbor Commodity All-Weather Strategy. Over the year to Sep 11, 2026 it returned +52.8% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.68% a year. By its holdings filed for Apr 30, 2026, 0% of the fund by weight is stocks the S&P 500 also holds, across 7 positions, with the top ten at 100.0%.
IBB in plain words
IBB is an index equity fund tracking the Biotechnology. Over the year to Sep 11, 2026 it returned +41.5% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.44% a year. By its holdings filed for Jun 30, 2026, 36% of the fund by weight is stocks the S&P 500 also holds, across 248 positions, with the top ten at 44.8%. It sat 6.5% below its high of Aug 19, 2026 on Sep 11, 2026.
Questions people ask
- Which returned more over the last year, HGER or IBB?
- In the year to Sep 12, 2026, with distributions reinvested, HGER returned +52.8% and IBB returned +41.5%, so HGER returned more. One year is one year; the longer windows are in the table.
- Which is cheaper, HGER or IBB?
- HGER charges 0.68% a year and IBB charges 0.44%, so IBB is cheaper. Fees come from each fund's prospectus.
- How much do HGER and IBB overlap with the S&P 500?
- By their latest filed holdings, 0% of HGER and 36% of IBB by weight is stocks the S&P 500 already holds. Between the two funds, 0% of their books are the same securities at the same weight.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, HGER against IBB, data as of Sep 12, 2026. https://etfiq.com/compare/any/HGER-IBB Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources